Mr. Carlson is a member of the Washington State Bar Association and practices corporate law for the firm of K&L Gates. Active in the legal community, he is currently co-chair of the Washington State Bar Association Corporate Act Revision Committee, past-chairman and current member of the Board of Trustees of Cornish College of the Arts, and a member of the Board of Trustees of Pilchuck Glass School.

Through activities supporting the University of Washington, Mr. Cable has developed an intimate involvement with the research community in the Northwest. Mr. Cable has more than 25 years of venture experience. Twenty of those years have been spent as a resident of Seattle and deeply involved in the development of the Northwest venture industry.

As president and chief executive officer of Washington Research Foundation, Mr. Howell has guided WRF from being an organization that identified, protected and licensed technologies to one with sufficient assets and expertise to foster the creation of early-stage technology-based companies.

Mr. Howell joined WRF in 1989 and shaped the most successful licensing program in the organization's history for generating a significant ongoing revenue stream. He continues to provide strategic direction for this effort.

Earlier in his career Mr. Howell was in medical sales and operations. Mr. Howell serves on several boards related to the mission and activities of WRF and WRF Capital, and is a Trustee of the Fred Hutchinson Cancer Research Center. He holds a bachelor of science in biochemistry from Washington State University.

Mr. Forman served as Chairman of the Financial Insurance Group in London, and as Managing Director of Allegiance Capital Partners. Prior thereto, he was a Managing Director of Chase Capital Markets. Mr. Forman is a co-founder of Halosource Corporation, which develops anti-microbial products. In addition, he co-founded a company providing web-based transmission and archival services for managing international trade documentation. He is currently a Trustee of the Seattle Symphony. Mr. Forman received a B.A. from Harvard College, a D.Phil. from Oxford, and a J.D. from Harvard Law School.

Mrs. Narodick served from 1989 to 1996 as Chairman and CEO of publicly held Edmark Corporation, which was one of the leading developers and publishers of early childhood educational software. Following the sale of Edmark to IBM, Mrs. Narodick served for 18 months as consultant to IBM, and as an independent e-learning consultant. In 1998, Mrs. Narodick was recruited to become the founding CEO of Apex Learning, Inc., an educational project to deliver Advanced Placement courses to high school students online.

Earlier in her career, Mrs. Narodick served for 14 years with Seafirst Corporation (now Bank of America) in several financial management capacities, including Senior Vice President and Corporate Controller, and Senior Vice President in charge of Business and Consumer Banking for the Seattle and King County Region. Mrs. Narodick has a B.A. from Boston University, M.A. in Teaching from Columbia Teachers College, and an M.B.A. from New York University. Mrs. Narodick serves on the Boards of several publicly held companies, including Puget Sound Energy, Penford Corporation, Solutia, Cray Computer and SumTotal Systems. She is a Trustee of the Fred Hutchinson Cancer Research Center and the Kline Galland Center.

Dr. George Thomas received his MD from Johns Hopkins Medical School in 1949 and specializes his practice in thoracic and vascular surgery. He has held appointments in surgery at the University of Washington since 1955 and became Clinical Professor of Surgery in 1978. During his career, he has authored over 70 publications.

Dr. Thomas has medical board certifications in surgery and thoracic surgery. He has served as President of the Washington State Chapter of American College of Surgeons, the Seattle Surgical Society, the Pacific Coast Surgical Association, the North Pacific Surgical Association and the Northwestern Medical Association, among others. Dr. Thomas is currently a consultant in vascular surgery at the Vascular Institute of the Northwest in the Swedish-Providence Medical Institute.

After graduation from the University of Illinois Law School, Mr. Uhlir practiced in Chicago for a few years before moving to Seattle, where he is a partner in the intellectual property law firm of Christensen O'Connor Johnson and Kindness PLLC specializing in patent and trademark prosecution, litigation and licensing. He is a past president of the Washington State Patent Law Association, Allied Arts of Seattle and the Broadmoor Golf Club, and is currently a Trustee of the Seattle Repertory Theatre and The Seattle Opera.

Mr. Uhlir was a co-founder of Immunex Corporation and in his practice advises inventors and business startups. His passions include golf, skiing, and his and his wife Camille's San Juan Island farm.

Mr. Simpson has over 27 years of experience in medical sales and marketing. He retired from Physio-Control after 20 years of service including senior management positions as Vice President of World Wide Marketing, International, and North American Sales.

During his tenure at Physio-Control he was involved with the divestiture from Eli Lilly, sale to Bain Capital, IPO in 1996, and acquisition by Medtronic in 1998. In 1999 Mr. Simpson founded Pacific Rim Medical Systems, a distributor of cardiovascular devices. Mr. Simpson is also chairman of the R. Hunter Simpson Foundation and a general partner in Diamond Head Reef Partners, a private investment firm. In addition to his WRF commitments, Mr. Simpson is an external advisory board member for the University of Washington’s Department of Global Health and a board member for Seattle Medic One Foundation.

Dr. Dooley serves as adjunct faculty in technology strategy, entrepreneurship and venture capital in the Business School and the Department of Computer Science and Engineering at the University of Washington. She also works with the Center for Innovation and Entrepreneurship (CIE), involving students in all aspects of company creation, technology commercialization and investment. She was awarded the University's Distinguished Teaching Award in 1997.

Dr. Dooley has a B.Sc. and M.Eng. from the University of Limerick in Ireland, and an MBA and Ph.D. from the University of Washington. She spent her early career in design engineering with Digital Equipment Corporation and in marketing with Mosaix. She has served on the boards of Social Venture Partners, the Northwest Entrepreneur Network and the League of Education Voters Foundation, among others.

David Galas is Professor and Senior Vice President at the Institute for Systems Biology where he conducts his research, and leads multi-investigator projects. Formerly he was Chief Science Officer for Life Sciences of the Battelle Memorial Institute. He was previously Chancellor, Chief Scientific Officer and Norris Professor of Applied Life Science at the Keck Graduate Institute of Applied Life Sciences (KGI), in Claremont, CA, a research and educational institution in the applied life sciences, which he co-founded. Prior to that Dr. Galas served as President and Chief Scientific Officer of Seattle-based Chiroscience R&D, Inc., a genomics and drug discovery company formed through the acquisition of Darwin Molecular Corporation, which Dr. Galas co-founded in 1993 and served as CEO and Chief Scientific Officer. Dr. Galas has also served as Director for Health and Environmental Research at the U.S. Department of Energy's Office of Science, where he headed the DOE's Human Genome Project from 1990 to 1993, while on leave from the University of Southern California, where he was Professor of Molecular Biology and chairman.

Dr. Galas' Ph.D. training was in physics, from the University of California. He has also held research positions at the University of Geneva, Switzerland, and the University of California's Lawrence Livermore National Laboratory. His broad research interests include areas of molecular biology and human genetics, the development and application of new technologies in the life sciences, and the understanding of complex biological networks. He is the recipient of several awards including the Smithsonian Institution-Computer World Pioneer award in 1999. He has served on many federal, university and corporate boards, including several biotechnology companies he has co-founded, and on various advisory and National Research Council committees, including the Board on Life Science, and the National Cancer Policy Board. He chairs the Board of Directors of the Fannie and John Hertz Foundation. He is a lifetime National Associate of the National Academy of Sciences.